Cardiac Hypertrophy Caused by Peroxisome Proliferator- Activated Receptor-γ Agonist Treatment Occurs Independently of Changes in Myocardial Insulin Signaling-Reference-Cited by-同舟云学术

Cardiac Hypertrophy Caused by Peroxisome Proliferator- Activated Receptor-γ Agonist Treatment Occurs Independently of Changes in Myocardial Insulin Signaling

Published:2007-12-01 Issue:12 Volume:148 Page:6047-6053
ISSN:0013-7227
Container-title:Endocrinology
language:en
Short-container-title:

Author:

Sena Sandra¹,Rasmussen Isaac R.¹,Wende Adam R.¹,McQueen Alfred P.²,Theobald Heather A.¹,Wilde Nicole¹,Pereira Renata Oliveira¹,Litwin Sheldon E.²,Berger Joel P.³,Abel E. Dale¹

Affiliation:

1. Division of Endocrinology, Metabolism and Diabetes, and Program in Human Molecular Biology and Genetics (S.S., I.R.R., A.R.W., H.A.T., N.W., R.O.P., E.D.A.), University of Utah, School of Medicine, Salt Lake City, Utah 84112;

2. Division of Cardiology (A.P.M., S.E.L.), University of Utah School of Medicine, Salt Lake City, Utah 84132;

3. Department of Metabolic Disorders (J.P.B.), Merck Research Laboratories, Rahway, New Jersey 07065

Publisher

The Endocrine Society

Subject

Endocrinology

Link

http://academic.oup.com/endo/article-pdf/148/12/6047/10727000/endo6047.pdf

Reference40 articles.

1. The mechanisms of action of PPARs.;Berger;Annu Rev Med,2002

2. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARγ agonists: a potential mechanism of insulin sensitization.;Combs;Endocrinology,2002

3. New drug targets for type 2 diabetes and the metabolic syndrome.;Moller;Nature,2001

4. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ.;Li;J Clin Invest,2004

5. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.;Collins;Arterioscler Thromb Vasc Biol,2001

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of the endocannabinoid system mediates cardiac hypertrophy induced by rosiglitazone;Acta Pharmacologica Sinica;2022-02-21

2. PPAR control of metabolism and cardiovascular functions;Nature Reviews Cardiology;2021-06-14

3. Insulin Signaling In the Heart;American Journal of Physiology-Endocrinology and Metabolism;2021-05-31

4. Maintaining Myocardial Glucose Utilization in Diabetic Cardiomyopathy Accelerates Mitochondrial Dysfunction;Diabetes;2020-05-04

5. Bitter gourd (Momordica charantia) possess developmental toxicity as revealed by screening the seeds and fruit extracts in zebrafish embryos;BMC Complementary and Alternative Medicine;2019-07-24